Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.3125
-0.0125 (-3.85%)
Sep 25, 2026, 1:43 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 11.23 million as of September 24, 2026. Its market cap has decreased by -51.02% in one year.
Market Cap
11.23M
Enterprise Value
10.03M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.31
ChartMarket Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 11.23M, a decrease of -88.49%. That is a compound annual growth rate of -36.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 11.23M | -61.27% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 23.79M |
| SkinBioTherapeutics | 19.44M |
| IXICO | 16.42M |
| Oxford BioDynamics | 15.46M |
| Palatin Technologies | 14.56M |
| Fusion Antibodies | 14.08M |
| Genflow Biosciences | 11.04M |
| Solvonis Therapeutics | 7.83M |